ArticleSurgical case reports2025

Conversion Surgery Following Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma with Para-Aortic Lymph Node Metastases: A Case of Complete Hepatic Response and Lymphatic Resistance.

Sunao Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.